Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.
Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...
Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...
A federal judge has dismissed a lawsuit by a New York family who claimed the Department of Defense misled Americans into ...
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...
A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...
BioNTech's updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.
CSL and Arcturus Therapeutics report that their sa-mRNA COVID-19 vaccine, ARCT-154, delivered superior immunogenicity ...